Paperpal Prime Logo

Veterinary and Comparative Oncology : Impact Factor & More

eISSN: 1476-5829pISSN: 1476-5810

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q1Veterinary (all)
SNIP
1.29
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Veterinary and Comparative Oncology

Veterinary and Comparative Oncology Journal Specifications

Overview
Publisher WILEY
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Veterinary and Comparative Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Veterinary and Comparative Oncology

Raman Spectroscopy for Differentiating High- and Low-Grade Canine Cutaneous Mast Cell Tumours.
  • 23 Jun 2026
  • Veterinary and comparative oncology
The Definitive-Intent 10-Fraction Radiotherapy Protocol ('The Zurich Protocol') Yields Lasting Tumour Control and Survival in Dogs With Intracranial Meningiomas.
  • 16 Jun 2026
  • Veterinary and comparative oncology
Use of the IlluminOss Photodynamic Bone Stabilisation System Following Stereotactic Body Radiation Therapy for Limb-Sparing in Six Dogs With Presumptive Appendicular Osteosarcoma.
  • 12 Jun 2026
  • Veterinary and comparative oncology
Canine Urothelial DNA Mutations Are Not Associated With Total Trihalomethanes Concentrations in Municipal Drinking Water.
  • 1 Jun 2026
  • Veterinary and comparative oncology
Cabazitaxel Demonstrates Potent Antitumour Activity Against Canine Large-Cell Alimentary Lymphoma InVitro and InVivo.
  • 1 Jun 2026
  • Veterinary and comparative oncology
CD30 Expression in Neoplastic Mast Cells and the Presence of CD30+, CD3+, and PAX-5+ Tumour-Infiltrating Lymphocytes as Prognostic Markers in Canine Cutaneous Mast Cell Tumours.
  • 1 Jun 2026
  • Veterinary and comparative oncology
Raman Spectroscopy for Differentiating High- and Low-Grade Canine Cutaneous Mast Cell Tumours.
  • 23 Jun 2026
  • Veterinary and comparative oncology
The Definitive-Intent 10-Fraction Radiotherapy Protocol ('The Zurich Protocol') Yields Lasting Tumour Control and Survival in Dogs With Intracranial Meningiomas.
  • 16 Jun 2026
  • Veterinary and comparative oncology
Use of the IlluminOss Photodynamic Bone Stabilisation System Following Stereotactic Body Radiation Therapy for Limb-Sparing in Six Dogs With Presumptive Appendicular Osteosarcoma.
  • 12 Jun 2026
  • Veterinary and comparative oncology
Canine Urothelial DNA Mutations Are Not Associated With Total Trihalomethanes Concentrations in Municipal Drinking Water.
  • 1 Jun 2026
  • Veterinary and comparative oncology
Cabazitaxel Demonstrates Potent Antitumour Activity Against Canine Large-Cell Alimentary Lymphoma InVitro and InVivo.
  • 1 Jun 2026
  • Veterinary and comparative oncology
CD30 Expression in Neoplastic Mast Cells and the Presence of CD30+, CD3+, and PAX-5+ Tumour-Infiltrating Lymphocytes as Prognostic Markers in Canine Cutaneous Mast Cell Tumours.
  • 1 Jun 2026
  • Veterinary and comparative oncology

FAQs on Veterinary and Comparative Oncology